TY  - GEN
AU  - Levy,Antonin
AU  - Menard,Jean
AU  - Albiges,Laurence
AU  - Loriot,Yohann
AU  - Di Palma,Mario
AU  - Fizazi,Karim
AU  - Escudier,Bernard
TI  - Second line treatment of metastatic renal cell carcinoma: The Institut Gustave Roussy experience with targeted therapies in 251 consecutive patients
SN  - 1879-0852
PY  - 2013///0705
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Analysis of Variance
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Bevacizumab
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Cardiovascular Diseases
KW  - chemically induced
KW  - Disease Progression
KW  - Drug Administration Schedule
KW  - Everolimus
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Indoles
KW  - Kaplan-Meier Estimate
KW  - Kidney Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Niacinamide
KW  - Phenylurea Compounds
KW  - Pyrroles
KW  - Sirolimus
KW  - Sorafenib
KW  - Sunitinib
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1016/j.ejca.2013.02.003
ER  -